GlassScriptPhysician profile
Arun Antony
NPI 1386899235
$961.84
in general payments reported to CMS, 2019-2025
12 companies · $88.90 in 2025
The $88.90 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2021: $229 · 2022: $53.80 · 2023: $226 · 2024: $155 · 2025: $88.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $196.76 | 2021 | |
| Eisai INC. | $144.49 | 2019-2021 | |
| Sk Life Science, INC. | $138.65 | 2024 | Xcopri |
| Medtronic, INC. | $136.54 | 2023-2025 | Percept PC Brainsense, Stealthstation S8 Platform |
| Novocure INC. | $97.05 | 2023 | Optune |
| Neuropace, INC. | $97.00 | 2019 | |
| Ucb, INC. | $51.98 | 2022-2025 | Briviact, Fintepla |
| Neurelis, INC. | $35.95 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $30.97 | 2023 | Austedo, Austedo Xr |
| Pfizer INC. | $16.98 | 2025 | |
| Jazz Pharmaceuticals INC. | $15.47 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Antony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.